chemtronbio产品代理
chemtronbio产品代理
Chemtron拥有17000多平方米的生产厂房，拥有先进的体外诊断试剂研发、生产、质检设备和仪器，年生产能力3.2亿支。在美国加利福尼亚州圣地亚哥，Chemtron（美国）公司建立了独资的产品开发中心和生产工厂。现有员工194人，其中本科以上学历110人，其中博士3人，硕士10人，占公司员工总数的52.9%。 2004年，Chemtron通过了ISO13485权威质量体系国际认证； 2005年3月，Chemtron通过了国家食品药品监督管理局的GMP认证； 2009年被列入上海市政府生物医药产业化项目； Chemtron主要产品获得欧盟CE证书； 12个药检产品系列获得美国FDA认证。
Chemtron 在美国和中国建立了一流的“Chemtron 研发技术中心”。 Chemtron基于单克隆抗体技术和检验医学技术平台，加快了产品的研发和营销。 Chemtron 不断开发和推出快速、灵敏、特异和准确的体外诊断产品。 Chemtron现拥有国家注册商标“Chemtrue”系列体外诊断试剂，产品共6个系列40多个品种：如药物检测；肿瘤检测；传染病检测；心血管疾病检测；激素检测及POCT快速定量智能仪器，配套CRP、HCG、MAU、cTnI、心肌梗死三合一、PCT、D2聚合物等产品。
Chemtron始终坚持“质量、信誉、服务、至诚”的经营理念和“完美品质、规范管理、创新、真诚服务”的质量方针。 Chemtron的产品销往全球70多个国家和地区，如美国、俄罗斯、欧洲、南美、中东、东亚等，Chemtron愿与您携手，解除人类的苦难！
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R & D, production, sales and services of in-vitro rapid detection
of diagnostic reagents.
Chemtron has Production Plants over 17000 square meters with facilities for advanced R & D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor’s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron’s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States.
Chemtron has established a first-class “Chemtron R & D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R & D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a
series of in-vitro diagnostic reagents under the national registered trademark "Chemtrue", with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products.
Chemtron has always adhered to the business philosophy of "quality, reputation, service and sincerity" and the quality policy of "perfect quality, standardized management, innovation and sincere service". Chemtron’s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
